4月29日,药明康德(02359)盘中上涨6.44%,截至09:34,报61.95元/股,成交1.33亿元。药明康德提供一体化的新药研发和生产服务,覆盖化学药、生物学研究、临床前测试及临床试验等领域,服务全球超过6,000家合作伙伴。公司通过CRDMO业务模式降低研发门槛,提升研发效率,致力于为全球患者带来创新治疗方案。截至2025年一季报,药明康德营业总收入96.55亿元、净利润35.36亿元。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.